Informations techniques
Exploitant
OMNIVISION GmbH
Présentation
BRIMONIDINE OMNIVISION 2 mg/ml, collyre en solution en récipients unidoses - 60 récipients unidoses de 0,35 ml (CIP : 34009 301 500 3 0)
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
8CBSRYBNnqBkjk0J